FDG-PET can predict response to chemotherapy in oesophageal cancer.

被引：0
|
作者：
Wegner, EA
Rankin, SC
Galani, E
Rottenberg, G
Marx, G
Ho-Shon, I
Harper, PG
机构：
[1] Guys & St Thomas Hosp, Clin PET Ctr, London SE1 9RT, England
[2] Guys & St Thomas Hosp NHS Trust, Dept Radiol, London, England
[3] Guys & St Thomas Hosp NHS Trust, Dept Oncol, London, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [41] Evolving role of FDG-PET/CT in the management of breast cancer.
    Zadeh, Mandi Zirakchian
    Paydary, Koosha
    Emamzadehfard, Sahra
    Raynor, William
    Werner, Thomas
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [42] Comparison of FDG-PET, CT and tumormarkers for staging of testicular cancer.
    Cremerius, U
    Adam, G
    Zimny, M
    Jakse, G
    Buell, U
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 249P - 250P
  • [43] FDG-PET for evaluating the effectiveness of endocrine therapy for prostate cancer.
    Oyama, N
    Akino, H
    Suzuki, Y
    Matsuta, Y
    Maekawa, M
    Nakai, M
    Kanamaru, H
    Sadato, N
    Yonekura, Y
    Okada, K
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 256P - 257P
  • [44] FDG-PET in the follow-up of differentiated thyroid cancer.
    Grunwald, F
    Menzel, C
    Bender, H
    Palmedo, H
    Klemm, E
    Ruhlmann, J
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 527 - 527
  • [45] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    van de Putte, E. E. Fransen
    Vegt, E.
    Mertens, L. S.
    Bruining, A.
    Hendricksen, K.
    van der Heijden, M. S.
    Horenblas, S.
    van Rhijn, B. W. G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (09) : 1585 - 1591
  • [46] FDG-PET/CT for Predicting Response to Neoajuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer
    Champion, L.
    Lerebours, F.
    Alberini, J.
    Edeline, V.
    Wartski, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S474 - S474
  • [47] MRI and FDG-PET for Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
    Aiba, Toshisada
    Uehara, Keisuke
    Nihashi, Takashi
    Tsuzuki, Toyonori
    Yatsuya, Hiroshi
    Yoshioka, Yuichiro
    Kato, Katsuhiko
    Nagino, Masato
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) : 1801 - 1808
  • [48] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    E. E. Fransen van de Putte
    E. Vegt
    L. S. Mertens
    A. Bruining
    K. Hendricksen
    M. S. van der Heijden
    S. Horenblas
    B. W. G. van Rhijn
    International Urology and Nephrology, 2017, 49 : 1585 - 1591
  • [49] The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment
    Bombardieri, Emilio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (07) : 753 - 758
  • [50] The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment
    Emilio Bombardieri
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 753 - 758
12345